How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
PMS And Menstrual Health Supplements Market
- By Product Type: Herbal Supplements, Vitamin and Mineral Supplements, Amino Acid Supplements, Probiotic Supplements, Hormonal Supplements
- By Form: Capsules, Tablets, Powders, Liquid Extracts, Gummies
- By Distribution Channel: Pharmacies and Drug Stores, Online Retail, Health and Wellness Stores, Supermarkets and Hypermarkets, Direct Sales
- By Target Consumer: Adolescents, Women of Reproductive Age, Perimenopausal Women, Athletes and Fitness Enthusiasts
- By Key Ingredients: Chasteberry (Vitex agnus-castus), Calcium and Magnesium, Vitamin B6, Evening Primrose Oil, Ginkgo Biloba
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Herbal Supplements leads By Product Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 16 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 305 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.184 →
- 12 Company Profiles 16 players: SWOT & benchmarking p.192 →
Full report · locked preview
Everything inside the PMS And Menstrual Health Supplements Market report
A complete, evidence-based study - 12 chapters and 128 sections covering market size, segmentation across 5 axes, regional analysis and 16 company profiles, forecast to 2033.
Segmentation covered
Product Type 5
Form 5
Distribution Channel 5
Target Consumer 4
Key Ingredients 5
Companies profiled
Reckitt Benckiser Group plc
Bayer AG
Pfizer Inc.
Church & Dwight Co. Inc.
Nature's Way Products
LLC
GNC Holdings Inc.
Himalaya Global Holdings Ltd.
Amway Corporation
NOW Foods
New Chapter Inc.
Vitabiotics Ltd.
+4 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
16 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Reckitt Benckiser Group plc
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Bayer AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Pfizer Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Church & Dwight Co. Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Nature's Way Products
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →LLC
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →GNC Holdings Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →Himalaya Global Holdings Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Amway Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →NOW Foods
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →New Chapter Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Vitabiotics Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Herbalife Nutrition Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Swisse Wellness Pty Ltd
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →MegaFood
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Garden of Life
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$8,090M by 2033 · 6.7% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Herbal Supplements52.1
- Vitamin and Mineral Supplements13.1
- Amino Acid Supplements7.2
- Probiotic Supplements9.8
- Hormonal Supplements17.6
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,584M → $2,689M · 6.8%
Europe$1,104M → $1,961M · 7.4%
Asia Pacific$1,008M → $1,823M · 7.7%
Latin America$623.9M → $1,154M · 8.0%
Middle East and Africa$479.9M → $781.4M · 6.3%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →6.692026
6.712027
6.722028
6.742029
6.742030
6.762031
6.782032
6.782033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Reckitt Benckiser Group plc11.9
- Bayer AG24.3
- Pfizer Inc.7.4
- Church & Dwight Co. Inc.11.4
- Nature's Way Products6.9
- LLC10.1
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Type20.9%
Form25.2%
Distribution Channel16.0%
Target Consumer16.4%
Key Ingredients21.5%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America32.0
- Europe23.3
- Asia Pacific21.7
- Latin America13.7
- Middle East and Africa9.3
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Reckitt Benckiser Group plc | 83 | 96 | 75 | 74 | 73 | 85 | 81 |
| Bayer AG | 79 | 85 | 73 | 74 | 88 | 84 | 81 |
| Pfizer Inc. | 64 | 83 | 70 | 73 | 69 | 84 | 74 |
| Church & Dwight Co. Inc. | 71 | 58 | 71 | 73 | 59 | 82 | 69 |
| Nature's Way Products | 70 | 74 | 54 | 76 | 58 | 56 | 65 |
| LLC | 69 | 58 | 67 | 70 | 63 | 52 | 63 |
| GNC Holdings Inc. | 42 | 49 | 59 | 63 | 41 | 58 | 52 |
| Himalaya Global Holdings Ltd. | 35 | 56 | 38 | 54 | 52 | 44 | 47 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Reckitt Benckiser Group plc
- Bayer AG
- Pfizer Inc.
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Reckitt Benckiser Group plc | ◐ | ✓ | ✓ | − | − | ◐ |
| Bayer AG | ◐ | ✓ | ◐ | ◐ | ✓ | ✓ |
| Pfizer Inc. | ✓ | ✓ | − | ◐ | ◐ | ◐ |
| Church & Dwight Co. Inc. | − | ◐ | ✓ | ✓ | − | ✓ |
| Nature's Way Products | ✓ | ✓ | ◐ | ◐ | ◐ | ◐ |
| LLC | ◐ | ◐ | ✓ | ◐ | − | ◐ |
| GNC Holdings Inc. | − | − | ◐ | ◐ | − | ◐ |
| Himalaya Global Holdings Ltd. | − | − | − | − | − | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Reckitt Benckiser Group plc81
2Bayer AG81
3Pfizer Inc.74
4Church & Dwight Co. Inc.69
5Nature's Way Products65
6LLC63
7GNC Holdings Inc.52
8Himalaya Global Holdings Ltd.47
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Reckitt Benckiser Group plcBayer AG
Challenger2
Strong scale, closing on the leaders.
Pfizer Inc.Church & Dwight Co. Inc.
Contender2
Focused players with pockets of strength.
Nature's Way ProductsLLC
Niche2
Specialists in a single segment or region.
GNC Holdings Inc.Himalaya Global Holdings Ltd.
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Product Type in North America, then scale across PMS And Menstrual Health Supplements Market — a $82M beachhead inside a $1.25B market.
Beachhead (SOM)$82Mobtainable near-term
Serviceable (SAM)$466Mreachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale3 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion87 fit
Herbal Supplements
Best fit — highest urgency & budget in Product Type.
Economic buyer78 fit
Vitamin and Mineral Supplements
Strong fit — clear ROI and a fast path to value.
End user64 fit
Amino Acid Supplements
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Form & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Distribution Channel
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales44%
Partner / channel26%
Digital / self-serve23%
Marketplaces6%
Positioning & messaging
§GTM 2 · p.194 →For Product Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win PMS And Menstrual Health Supplements Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified41%
Sales qualified22%
Evaluation13%
Closed-won7%
$12.2KCAC
$59KLTV
4.8:1LTV : CAC
< 3 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
PMS And Menstrual Health Supplements Market is a durable-growth opportunity — $4.88B by 2033, compounding at 8.0%.
TAM · 2025$2.63Btoday
TAM · 2033$4.88Bforecast
CAGR8.0%2027–2033
Cumulative$32.9Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$4.88BTotal addressable market
SAM$2.04BServiceable available market
SOM$388MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →8.0% CAGR
Demand compounds through 2033, outpacing GDP across Product Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Type moving from early to mainstream — durable secular demand.
Consolidation upside
16+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$4.88BLarge & growingTAM by 2033 at 8.0% CAGR
$2.04BServiceable nowreachable with today’s model
$388MBeachhead winobtainable near-term share
16+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$3.81BBear5.2% CAGR
$4.88BBase8.0% CAGR
$6.25BBull10.6% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Form optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
PMS And Menstrual Health Supplements Market — a $1.27B market by 2033. Plan: grow share from 7.7% to 13.8%.
Market size · 2033$1.27Btotal addressable
Market CAGR4.2%2027–2033
Target share13.8%from 7.7% today
Revenue ambition$175Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 7.7% | 13.8% | Ahead |
| Revenue | $90M | $175M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | At risk |
| Gross margin | 35.3% | 45.5% | At risk |
| Customer retention | 89.1% | 97.0% | Ahead |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Form capability
A defensible second engine — invest in Form to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Form
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $21M capacity & capability investment
- Greenlight bolt-on M&A in Form
- Authorise North America expansion plan
- Fund R&D program for Product Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossAt risk
- Input-cost & supply riskOn track
- Regulatory / policy changeOn track
- Execution & talentAt risk
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the PMS And Menstrual Health Supplements Market conversation — a $8.21B market you can size, segment and defend in minutes.
Market size · 2033$8.21Btotal opportunity
Growth9.7%CAGR to 2033
Addressable buyers1,466+accounts in scope
Typical ROI6.4×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Type
Goal Grow share in Product Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →6.4×return on cost, year one
< 3 mopayback period
$76K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
16+players profiled in this market
Coverage includes
Reckitt Benckiser Group plcBayer AGPfizer Inc.Church & Dwight Co. Inc.Nature's Way ProductsLLCGNC Holdings Inc.Himalaya Global Holdings Ltd.+8 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your PMS And Menstrual Health Supplements Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
PMS And Menstrual Health Supplements Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →PMP22 Antibody Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportPMMA Synthetic Dentures Market
Market size, share, segmentation and regional forecast.
$5.8B market · 2025 base year
View reportPMMA Bone Cements Market
Market size, share, segmentation and regional forecast.
$5.3B market · 2025 base year
View reportPluripotin (SC1) Market
Market size, share, segmentation and regional forecast.
$679M market · 2025 base year
View reportPluripotent Stem Cell Culture Medium Market
Market size, share, segmentation and regional forecast.
$977M market · 2025 base year
View reportPlunger for Prefilled Syringe Market
Market size, share, segmentation and regional forecast.
$3.5B market · 2025 base year
View reportPlume Poppies Extracts Market
Market size, share, segmentation and regional forecast.
$1.6B market · 2025 base year
View reportPluggable Cardiac Monitor Market
Market size, share, segmentation and regional forecast.
$2.8B market · 2025 base year
View reportPLLA Dermal Fillers Market
Market size, share, segmentation and regional forecast.
$5.6B market · 2025 base year
View reportPLLA Bone Screw Market
Market size, share, segmentation and regional forecast.
$3.5B market · 2025 base year
View reportPlexus Stimulator Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportPlexiform Neurofibromas Treatment Market
Market size, share, segmentation and regional forecast.
$6.2B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.